Skip to main content

Peer Review reports

From: IL-2-free tumor-infiltrating lymphocyte therapy with PD-1 blockade demonstrates potent efficacy in advanced gynecologic cancer

Original Submission
3 Oct 2023 Submitted Original manuscript
1 Feb 2024 Reviewed Reviewer Report - Victor C. Kok
11 Feb 2024 Reviewed Reviewer Report
4 Mar 2024 Author responded Author comments - Jing Guo
Resubmission - Version 2
4 Mar 2024 Submitted Manuscript version 2
25 Mar 2024 Reviewed Reviewer Report - Victor C. Kok
27 Mar 2024 Reviewed Reviewer Report
9 Apr 2024 Author responded Author comments - Jing Guo
Resubmission - Version 3
9 Apr 2024 Submitted Manuscript version 3
28 Apr 2024 Reviewed Reviewer Report - Victor C. Kok
28 Apr 2024 Reviewed Reviewer Report
2 May 2024 Author responded Author comments - Jing Guo
Resubmission - Version 4
2 May 2024 Submitted Manuscript version 4
6 May 2024 Author responded Author comments - Jing Guo
Resubmission - Version 5
6 May 2024 Submitted Manuscript version 5
Publishing
7 May 2024 Editorially accepted
20 May 2024 Article published 10.1186/s12916-024-03420-0

You can find further information about peer review here.

Back to article page